Yıldız Pehlivan, D., Yıldız, H. and Kaya, G. (2025) “Dapagliflozin Modulates MicroRNA Expression in Type 2 Diabetes Patients with Diabetic Nephropathy: A Retrospective Study”, European Journal of Therapeutics, 31(1), pp. 1–10. doi: 10.58600/eurjther2520.